Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 134.18% | -158.76% | -152.83% | -163.48% | -127.16% |
| Total Depreciation and Amortization | 3.56% | -7.88% | -9.88% | -11.63% | -70.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 127.30% | -193.47% | 85.57% | -354.89% | -597.89% |
| Change in Net Operating Assets | -105.04% | -186.33% | 17.04% | 157.30% | 592.37% |
| Cash from Operations | -74.58% | -170.06% | -180.17% | -17.13% | 18.57% |
| Capital Expenditure | -9,912.50% | -- | -- | 90.12% | 113.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.52% | 159.78% | -116.18% | 41.89% | -- |
| Cash from Investing | -97.66% | 159.74% | -116.19% | 41.94% | 60,654.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 66.67% | 91.93% | -- | 66.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 0.09% | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 66.67% | 1.58% | -- | 66.67% |
| Foreign Exchange rate Adjustments | 95.19% | -184.00% | -151.03% | -86.64% | -168.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.74% | 157.60% | -433.34% | 44.28% | 3,283.88% |
